Health
FDA approves injectable treatment for HIV patients – OutSourcing-Pharma.com
The agency has given the thumbs up to ViiV’s once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.
The US Food and Drug Administration (FDA) has approved Cabenuva (cabotegravir and rilpivirine) as a complete regimen intended to treat human immunodeficiency virus type 1 (HIV-1) infection in adults. The injectable drug is designed to replace a current antiretroviral regimen in patients who are virologically suppressed on a stable antiretroviral regimen, with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
Cabenuva, a product from…
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General14 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
General13 hours ago‘I can’t start at zero now’: Aussies call for clarity after super cyber attack